Upadacitinib sustains its efficacy in non-radiographic axial spondyloarthritis through 2 years without presenting any new ...

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

The incidence of sudden cardiac arrest during marathons and half-marathons remained relatively stable over the past 2 decades ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary ...

The measles outbreak in Texas and New Mexico has grown to include nearly 450 cases in just 2 months, health officials reported.Meanwhile, health departments in two other states are investigating cases ...

Obstructive sleep apnea may increase the risk for Parkinson’s disease, but early intervention with continuous positive airway ...

Parker Institute for Cancer Immunotherapy has named Karen E. Knudsen, MBA, PhD, as its new CEO, according to a press ...

Opthea has discontinued development of sozinibercept in wet age-related macular degeneration, according to a press release.

Young adults with kidney disease have a high risk of transitioning from peritoneal dialysis to hemodialysis due to infections ...